Table 9.11b

Adjusted Patient Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 664 93.8% 0.9% 664 88.2% 1.3% 1,554 80.3% 1.1% 1,874 77.2% 1.2%
Primary Diagnosis Non-Cholestatic Cirrhosis 336 95.1% 1.2% 336 88.2% 2.0% 792 79.9% 1.7% 906 75.0% 1.9%
Cholestatic Liver Disease/Cirrhosis 136 96.5% 1.6% 136 94.4% 2.0% 280 89.4% 2.1% 308 86.6% 2.5%
Acute Hepatic Necrosis 33 81.4% 7.4% 33 72.1% 8.9% 78 66.2% 6.1% 104 71.2% 4.5%
Biliary Atresia 68 92.9% 3.8% 68 92.9% 3.8% 165 83.6% 4.2% 246 84.2% 2.7%
Metabolic Diseases 15 80.8% 9.9% 15 68.1% 12.0% 45 69.4% 7.5% 62 75.1% 5.6%
Malignant Neoplasms 28 90.6% 5.1% 28 74.3% 7.9% 85 64.9% 5.4% 109 57.5% 5.3%
Other 47 92.1% 3.8% 47 88.1% 4.7% 108 81.2% 4.4% 138 80.2% 3.8%
Unknown 1 + + 1 + + 1 + + 1 + +


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.